Redcare Pharmacy NV

RDC.DE·XETRA·Healthcare
Compare
77.80+3.00 (+4.01%)today
As of Oct 19, 11:40 AM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close74.80
Open74.95
Day range74.9078.00
52-week range30.2085.45
Off day high−0.26%
Off 52-week high−8.95%
Volume22.34K
Avg. volume (3M)85.54K
Market cap1.57B
EPS (TTM)-2.09
Forward P/E51.95
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.31
Shares outstanding20.18M
Short interest—
Earnings dateOct 29, 2026
Analyst target88.80
Profit margin−1.30%

Related companies

Compare ›

The stocks whose daily moves over the past year went most closely with RDC.DE's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
DOCMORRIS NDOCM.SW · Correlation 0.51 794.29M 15.58 +6.86%

What visitors to RDC.DE's page also look at.

Company Mkt cap Price Today
DOCMORRIS NDOCM.SW 794.29M 15.58 +6.86%
Gerresheimer AGGXI.DE 1.05B 30.44 +6.06%
Eckert & Ziegler SEEUZ.DE 797.85M 12.75 +3.49%
IONOS Group SEIOS.DE 4.59B 34.04 −1.62%
Hypoport SEHYQ.DE 516.02M 77.95 +6.56%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All RDC.DE news ›
MarketScreener·

Redcare Pharmacy Names New CEO

Redcare Pharmacy said Friday its supervisory board designated Peter Schmid von Linstow as the new chief executive officer, effective Oct. 1. The executive, currently deputy chairman of the online... Published on 08/28/2026 at 06:09 am EDT…

MarketScreener·Positive

Redcare Pharmacy NV : Deutsche Bank gives a Buy rating

Already positive, the research from Deutsche Bank and its analyst Jan Koch still consider the stock as a Buy opportunity. Redcare Pharmacy NV : Deutsche Bank gives a Buy rating Published on 09/18/2026 at 03:35 am EDT Latest news about…

MarketScreener·

Redcare Pharmacy NV: Relative Strength Chart - Stock Xetra

Compare Redcare Pharmacy NV with the company of your choice via a Relative Strength chart. Real-time RDC price, Xetra stock exchange Relative Strength Chart Redcare Pharmacy NV All financial news and data tailored to specific country…

MarketScreener·Positive

Redcare Pharmacy NV : Receives a Buy rating from Jefferies

Jefferies is positive on the stock with a Buy rating. The target price continues to be set at EUR 97. Redcare Pharmacy NV : Receives a Buy rating from Jefferies Published on 08/28/2026 at 08:03 am EDT Latest news about Redcare Pharmacy NV…

From articles in the 4Search news index.

In the news

10mentions in 30 days
10with it in the headline
Positivesentiment

Mentioned with

Astrazeneca5Astrazeneca Plc5Canaccord Genuity Group5Chardan Capital5Digital Look5Jefferies Financial Group5Rocket Pharmaceuticals5Rocket Pharmaceuticals, Inc5

People in the coverage

Benzinga6Danessa Lincoln6Kim Johansen6Chardan Capital5Michel Demare5Berenberg4

Themes

Healthcare10Equities6Reiterated Rating5Analysis4Astrazeneca4Buy Rating4Germany4Europe3

Most coverage from

  1. marketscreener.com10

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.